Research Supporting a Pilot Study of Metronomic Dapsone during Glioblastoma Chemoirradiation

by Richard E. Kast
Published 2021-02-01

Inhibiting the NLRP3 Inflammasome With Methylene Blue as Treatment Adjunct in Myelodysplasia

by Richard E. Kast
Published 2018-07-01

Paths for Improving Bevacizumab Available in 2018: The ADZT Regimen for Better Glioblastoma Treatment

by Richard E. Kast
Published 2018-09-01

Glioblastoma: Looking at the Currently Marketed Sigma-1 Agonists, Antagonists

by Richard E Kast
Published 2007-08-01

Ribavirin in Cancer Immunotherapies: Controlling Nitric Oxide Augments Cytotoxic Lymphocyte Function

by Richard E. Kast
Published 2003-01-01

OPALS: A New Osimertinib Adjunctive Treatment of Lung Adenocarcinoma or Glioblastoma Using Five Repurposed Drugs

by Richard E. Kast, Marc-Eric Halatsch, Rafael Rosell
Published 2021-05-01

Involvement of MicroRNA in T-Cell Differentiation and Malignancy

by Najmaldin Saki, Saeid Abroun, Masoud Soleimani, Saeideh Hajizamani, Mohammad Shahjahani, Richard E Kast, Yousef Mortazavi
Published 2015-03-01

Glioblastoma-synthesized G-CSF and GM-CSF contribute to growth and immunosuppression: Potential therapeutic benefit from dapsone, fenofibrate, and ribavirin

by Richard E Kast, Quentin A Hill, Didier Wion, Håkan Mellstedt, Daniele Focosi, Georg Karpel-Massler, Tim Heiland, Marc-Eric Halatsch
Published 2017-04-01

Augmentation of 5-Aminolevulinic Acid Treatment of Glioblastoma by Adding Ciprofloxacin, Deferiprone, 5-Fluorouracil and Febuxostat: The CAALA Regimen

by Richard E. Kast, Nicolas Skuli, Iacopo Sardi, Felix Capanni, Martin Hessling, Guido Frosina, Anton P. Kast, Georg Karpel-Massler, Marc-Eric Halatsch
Published 2018-11-01

A New Treatment Opportunity for DIPG and Diffuse Midline Gliomas: 5-ALA Augmented Irradiation, the 5aai Regimen

by Richard E. Kast, Alex P. Michael, Iacopo Sardi, Terry C. Burns, Tim Heiland, Georg Karpel-Massler, Francois G. Kamar, Marc-Eric Halatsch
Published 2020-01-01